Stuttgart - Delayed Quote EUR
Neuren Pharmaceuticals Ltd (NK9.SG)
6.25
+0.05
+(0.81%)
At close: April 25 at 8:04:04 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
-11,270
-11,270
184,925
3,599
-9,970
Investing Cash Flow
4,134
4,134
-211,485
-19
-10
Financing Cash Flow
-8,775
-8,775
3,619
-2
22,175
End Cash Position
3,153
3,153
17,094
40,180
36,783
Income Tax Paid Supplemental Data
39,738
39,738
11,840
--
--
Capital Expenditure
-10
-10
-40
-19
-10
Issuance of Capital Stock
1,660
1,660
3,637
--
23,281
Repurchase of Capital Stock
-10,435
-10,435
-18
-2
-1,106
Free Cash Flow
-11,280
-11,280
184,885
3,580
-9,980
12/31/2021 - 8/5/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade